Baricitinib

U.S. drugmaker Eli Lilly and Co today said its antibody drug combination has received an emergency use approval in India for the treatment of mild to moderate COVID-19 case. The…

View Post

COVID 19
Latest News

MSN Labs Enters Into Licensing Agreement With Lilly To Launch Baricitinib In India For COVID 19

May 13, 2021 17:24
Healthwire Bureau

MSN Labs (MSN) has announced today that they have entered into a royalty free, non-exclusive, voluntary license agreement with Eli Lilly and Company of USA for manufacturing and marketing of…

View Post

COVID 19
Latest News

Cilpla Enters Into A Licensing Agreement Eli Lilly To Make And Sell Baricitinib To Treat Covid-19

May 10, 2021 18:09
Healthwire Bureau

Indian drugmaker Cipla Ltd has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly’s arthritis drug baricitinib for the treatment of Covid-19…

View Post

Menu

Baricitinib

Covid-19: U.S. Drugmaker Eli Lilly’s Antibody Drug Combination Gets Emergency Use Approval In India

MSN Labs Enters Into Licensing Agreement With Lilly To Launch Baricitinib In India For COVID 19

Cilpla Enters Into A Licensing Agreement Eli Lilly To Make And Sell Baricitinib To Treat Covid-19

Reel Addiction Linked to High Blood Pressure in Young and Middle-Aged Adults: Study Highlights Health Risks

HMPV Virus Update: Decline Observed in Northern China Amid Global Concerns

HMPV Virus in India: Does Your Health Insurance Policy Cover Outbreaks?

Heart Health in Winter: 5 Best Superfoods to Keep Your Heart Warm and Clean Your Arteries Naturally

Ice Baths for Stress Relief: How Cold Water Therapy Can Sharpen Your Mind and Improve Sleep

Experts Warn Bird Flu Could Become the Next Pandemic Without Urgent Action

Gujarat Records Fifth HMPV Case: Elderly Man in Kutch Tests Positive

Weight Loss Tips: 7 Foods You Should Never Eat At Night After 10PM, As Per Ayurevda